Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 2009, p. 1682-1693, Vol. 29, No. 7
0270-7306/09/$08.00+0 doi:10.1128/MCB.01411-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Fernando J. Calero-Nieto,1,
,
Stephanie Valeaux,1
Suzana Hadjur,2
Euan W. Baxter,1,
Matthias Merkenschlager,2 and
Peter N. Cockerill1*
Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, St. James's University Hospital, Leeds LS9 7TF, United Kingdom,1 Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College, Du Cane Road, London W12 ONN, United Kingdom2
Received 8 September 2008/ Returned for modification 5 November 2008/ Accepted 9 January 2009
The human interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating-factor (GM-CSF, or CSF2) gene cluster arose by duplication of an ancestral gene. Although just 10 kb apart and responsive to the same signals, the IL-3 and GM-CSF genes are nevertheless regulated independently by separate, tissue-specific enhancers. To understand the differential regulation of the IL-3 and GM-CSF genes we have investigated a cluster of three ubiquitous DNase I-hypersensitive sites (DHSs) located between the two genes. We found that each site contains a conserved CTCF consensus sequence, binds CTCF, and recruits the cohesin subunit Rad21 in vivo. The positioning of these sites relative to the IL-3 and GM-CSF genes and their respective enhancers is conserved between human and mouse, suggesting a functional role in the organization of the locus. We found that these sites effectively block functional interactions between the GM-CSF enhancer and either the IL-3 or the GM-CSF promoter in reporter gene assays. These data argue that the regulation of the IL-3 and the GM-CSF promoters depends on the positions of their enhancers relative to the conserved CTCF/cohesin-binding sites. We suggest that one important role of these sites is to enable the independent regulation of the IL-3 and GM-CSF genes.
Published ahead of print on 21 January 2009.
F.M. and F.J.C.-N. contributed equally to this study.
Present address: Department of Haematology, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Cambridge, United Kingdom.
Present address: YCR p53 Research Unit, Department of Biology, University of York, York YO10 5DD, United Kingdom.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»